Carterra® is privately held and is the leading provider of high-throughput technologies designed to accelerate and improve the discovery of novel therapeutic candidates. Carterra’s LSA® instrument, software, and consumables for biotherapeutic discovery and characterization deliver up to 100 times the throughput of existing platforms in 10% of the time while using only 1% of the sample required by other systems. The LSA combines patented microfluidics technology with real-time high-throughput Surface Plasmon Resonance (HT-SPR) and industry-leading data analysis and visualization software to revolutionize mAb screening. The new LSAXT provides enhanced optics to enable additional applications in biotherapeutic discovery and characterization.
Rmax refers to the maximum observed RU binding value (extrapolated or measured) when all surface ligand binding sites are occupied during the association phase. Req refers to the RU response observed during the association phase once equilibrium is achieved between the ligand and the analyte that is being cycled over the surface. Req would be analyte concentration dependent. The concentration of the Ligand, Analyte and their inherent affinity (KD) define the occupancy % at equilibrium.
Robotized measurement ---> ru-vid.com/video/%D0%B2%D0%B8%D0%B4%D0%B5%D0%BE-dEW5YO7l5TQ.html For more details see ---> www.nature.com/articles/s43246-022-00235-5
The first shot put me down for a week, high fever, sweating, & fatigue. the 2nd shot put me down for 5 weeks, with pumping heart and sinus. will the 3rd shot kill me? nobody seems to care massive adverse responses. any assays to predict the survival possibility?
Greetings! Thanks for watching and for your comment. I support our RU-vid followers-please message me at cgiddens@carterra-bio.com and I will work with you directly on pricing and other information. Thanks!
Thanks for your interest and glad you found the information useful! We would be happy to connect you with one of our Sales Executives to learn more. Please reach out to Christian Giddens at cgiddens@carterra-bio.com
